CholesterolFamily health

Familial hypercholesterolemia: when high cholesterol is a family issue

CardioTrack editorialAI-assisted evidence summaryPublished 5 September 2026 4 min read
Three generations of a family beside a branching paper-cut tree with coral heart-shaped leaves.
AI-generated editorial illustration. Conceptual, not a diagnostic image or a medical diagram.
About this article: AI-assisted, not independently clinically reviewed

Prepared with AI-assisted research using the sources below. Not independently reviewed by a clinician. Guidance and individual circumstances can change; use this article to prepare for a clinical conversation, not to choose treatment.

Sources checked 2026-09-05. Last updated 2026-09-05.

The short version

  • Very high LDL-C and early family heart disease are clues, not a diagnosis by themselves.
  • Healthy habits remain valuable, but inherited high LDL often needs medication too.
  • Family screening can find affected relatives before symptoms develop.

High cholesterol is often discussed as if it were entirely a consequence of food choices. Familial hypercholesterolemia, or FH, is an important reason that explanation can be unfair and medically incomplete. Inherited difficulty clearing LDL cholesterol can expose arteries to high levels from early life, long before a person feels unwell.

Evidence: CDC 2025: about familial hypercholesterolemia

Clues worth bringing to a clinician

An adult LDL-C above 190 mg/dL, approximately 4.9 mmol/L, is a reason to consider FH, especially when relatives developed coronary disease unusually young. It is not enough to diagnose FH on its own. Some people have physical signs, but many do not, and feeling fit does not rule out inherited high cholesterol.

Evidence: CDC 2025: about familial hypercholesterolemia

NICE recommends checking for other causes of high cholesterol, obtaining two LDL-C measurements and using recognised diagnostic criteria. A clinician may consider genetic testing or specialist referral. The assessment needs the untreated result when available, because a lower result on medicine does not erase the history that led to treatment.

Evidence: NICE CG71: familial hypercholesterolaemia identification and management

What a family diagnosis means

In the common inherited form, an affected parent has a 50% chance of passing the causal gene to each child. This is an inheritance probability, not a statement that a child has a 50% chance of a heart attack. Each pregnancy is a separate event. Rarer forms exist, so a family's actual pattern should be explained by the clinical team.

Evidence: GeneReviews: familial hypercholesterolemia and genetic counselling

Cascade screening means working outward from an identified person to relatives who may also be affected. NICE recommends cascade DNA testing when a family's genetic diagnosis is established, beginning with close relatives and extending when appropriate. Screening is an opportunity to detect risk before symptoms, not an instruction to label relatives based on appearance or a family story.

Evidence: NICE CG71: familial hypercholesterolaemia identification and management

Why finding it early matters

A 2019 study followed a cohort originally treated for FH in childhood. By age 39, cumulative cardiovascular events were reported in 1% of those treated from childhood compared with 26% of their affected parents; cardiovascular deaths were 0% and 7%, respectively. The result supports the importance of early identification and sustained care.

Evidence: Luirink et al., NEJM 2019: 20-year follow-up of childhood FH treatment

However, that was a long-term generational comparison, not 20 years of random assignment to treatment or no treatment. Parents and children lived through different eras of care and prevention. The exact difference cannot be promised to an individual family, and it does not supply a child's medicine or dose. Those decisions belong with an appropriately qualified clinician.

Evidence: Luirink et al., NEJM 2019: 20-year follow-up of childhood FH treatment

Healthy habits and medication are not competitors

Food choices, activity and avoiding tobacco still matter, but FH frequently requires cholesterol-lowering medication as well. Needing treatment is not evidence of poor effort. Equally, medication is not permission to ignore other risk factors. Ask for a plan that addresses both the inherited LDL exposure and the parts of cardiovascular health you can influence.

Evidence: CDC 2025: about familial hypercholesterolemia · GeneReviews: familial hypercholesterolemia and genetic counselling

Build a useful family record

  • List parents, siblings and children, then note any known cholesterol diagnosis or early heart disease. Record the age at the event if possible.
  • Separate confirmed facts from uncertain recollections. 'Heart problem in their forties, diagnosis unknown' is more honest than inventing a diagnosis.
  • Bring old lipid reports and the medication history that explains changes between them.
  • Ask whether specialist assessment, genetic counselling or screening for children is appropriate. Do not wait for symptoms to raise the question.
  • Share an invitation to seek testing without sharing another relative's private report without permission.

Evidence: NICE CG71: familial hypercholesterolaemia identification and management · GeneReviews: familial hypercholesterolemia and genetic counselling

A useful next step is often a short message: 'A clinician is checking whether high cholesterol runs in our family. You may want to discuss screening with your own doctor.' That leaves room for consent and individual care. The goal is coordinated prevention, not turning one person's result into a diagnosis for everyone.

This article is educational and is not medical advice, a diagnosis, or a treatment recommendation. CardioTrack is not intended for diagnosis or treatment. Always discuss your own results with a qualified clinician.

Sources and further reading